Literature DB >> 8443492

Gangliosides and neurological diseases.

G Doria, G Tettamanti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443492      PMCID: PMC1676576          DOI: 10.1136/bmj.306.6871.204-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Gangliosides and neurological diseases.

Authors:  P O Behan; B A Haniffah
Journal:  BMJ       Date:  1992-11-28

Review 2.  Glycosphingolipids that can regulate nerve growth and repair.

Authors:  A C Cuello
Journal:  Adv Pharmacol       Date:  1990

Review 3.  Antibody detection in Guillain-Barré syndrome.

Authors:  L Svennerholm; P Fredman
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Modulation of specific immunity by ventral hippocampal formation in albino rats.

Authors:  R S Devi; A Namasivayam
Journal:  J Neuroimmunol       Date:  1991-07       Impact factor: 3.478

5.  Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.

Authors:  F H Geisler; F C Dorsey; W P Coleman
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

6.  Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins.

Authors:  E Nobile-Orazio; G Legname; R Daverio; M Carpo; A Giuliani; S Sonnino; G Scarlato
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

Review 7.  A review of the immunogenic and immuno-modulatory properties of glycosphingolipids.

Authors:  D M Marcus
Journal:  Mol Immunol       Date:  1984-11       Impact factor: 4.407

  7 in total
  2 in total

1.  Capability of ganglioside GM1 in modulating interactions, structure, location and dynamics of peptides/proteins: biophysical approaches: interaction of ganglioside GM1 with peptides/proteins.

Authors:  Ummul Liha Khatun; Anindita Gayen; Chaitali Mukhopadhyay
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

2.  Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides.

Authors:  M Massarotti; R Matano
Journal:  BMJ       Date:  1994-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.